Emcure Pharmaceuticals (India) Top Management
EMCURE Stock | 1,318 39.65 2.92% |
Emcure Pharmaceuticals employs about 10 people. The company is managed by 10 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Analysis of Emcure Pharmaceuticals' management performance can provide insight into the company performance.
Satish Mehta CEO MD CEO |
Samit Mehta President President Director |
Emcure |
Emcure Pharmaceuticals Workforce Comparison
Emcure Pharmaceuticals is currently under evaluation in number of employees category among its peers. The total workforce of Drug Manufacturers - Specialty & Generic industry is currently estimated at about 38,261. Emcure Pharmaceuticals adds roughly 0.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers - Specialty & Generic industry.
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13. Emcure Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Emcure Pharmaceuticals Price Series Summation is a cross summation of Emcure Pharmaceuticals price series and its benchmark/peer.
Emcure Pharmaceuticals Notable Stakeholders
An Emcure Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Emcure Pharmaceuticals often face trade-offs trying to please all of them. Emcure Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Emcure Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Satish Mehta | MD CEO | Profile | |
Samit Mehta | President Director | Profile | |
Naveen Soni | Director Relations | Profile | |
Mukund Gurjar | Chief Director | Profile | |
Namita Thapar | Executive Director | Profile | |
Sunil Mehta | Executive Director | Profile | |
Chetan Sharma | Company Officer | Profile | |
Vikas Thapar | Strategy Development | Profile | |
Rajesh Nair | Executive Resources | Profile | |
Tajuddin Shaikh | Chief Officer | Profile |
About Emcure Pharmaceuticals Management Performance
The success or failure of an entity such as Emcure Pharmaceuticals often depends on how effective the management is. Emcure Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Emcure management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Emcure management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Emcure Pharmaceuticals is entity of India. It is traded as Stock on NSE exchange.
Please note, the presentation of Emcure Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Emcure Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Emcure Pharmaceuticals' management manipulating its earnings.
Emcure Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Emcure Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Emcure Pharmaceuticals within its industry.Emcure Pharmaceuticals Manpower Efficiency
Return on Emcure Pharmaceuticals Manpower
Revenue Per Employee | 6.9B | |
Revenue Per Executive | 6.9B |
Complementary Tools for Emcure Stock analysis
When running Emcure Pharmaceuticals' price analysis, check to measure Emcure Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emcure Pharmaceuticals is operating at the current time. Most of Emcure Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Emcure Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emcure Pharmaceuticals' price. Additionally, you may evaluate how the addition of Emcure Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |